Multicentre randomized controlled studies now demonstrate high efficacy of topical
photodynamic therapy (PDT) for actinic keratoses, Bowen's disease (BD) and superficial …

This article summarizes recommendations reached following a systematic literature review
and expert consensus on the diagnosis and management of cutaneous squamous cell …

British Association of Dermatologists' guidelines for the management of squamous cell
carcinoma in situ (Bowen's disease) 2014 | British Journal of Dermatology | Oxford Academic …

Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses,
squamous cell carcinoma in-situ, superficial and certain thin basal cell carcinomas …

Photodynamic therapy (PDT) is a noninvasive procedure that involves a photosensitizing
drug and its subsequent activation by light to produce reactive oxygen species that …

Background Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group
of rare diseases characterized by exacerbated skin and/or mucosal fragility and blister …

Epidermolysis bullosa (EB), notably severe recessive dystrophic EB (RDEB-S), is associated
with increased risk of aggressive mucocutaneous squamous cell carcinomas, the major …

Photodynamic therapy is a relatively new and rapidly evolving therapeutic option in
dermatology. Initially used for the treatment of actinic damage and nonmelanotic skin …

Epidermolysis bullosa (EB) is a group of rare congenital diseases caused by mutations in
structural proteins of the dermal/epidermal junction that are characterized by extreme …

Photodynamic therapy (PDT) is based on the association of a light source and light sensitive
agents in order to cause the selective death of tumor cells. To evaluate topical 5 …